Healthcare & Life Sciences

Locemia

acquiredacquired
acquired
Stage

About

Locemia develops a needle-free intranasal glucagon powder designed to simplify rescue treatment for severe hypoglycemia in diabetes patients.

Explore Locemia's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.